Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IC ClearLy Trial
2009-013498-17Phase 3Suspended
- Sponsor
- Cardiology Department, University Hospital of Modena
- Start
- Oct 2009
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of abciximab in myocardial infarction (MI) and acute coronary syndrome (ACS) (2 arms), sponsored by Cardiology Department, University Hospital of Modena. Primary endpoint: Infarct size on cardiac MRI. Started Oct 2009; status: suspended.
02
Drugs
abciximab
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on 2009-013498-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013498-17.